Live Oak Investment Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.77M Buy
13,763
+126
+0.9% +$14.7K 0.95% 27
2026
Q1
$1.64M Sell
13,637
-12,795
-48% -$1.48M 0.97% 25
2025
Q4
$2.78M Buy
26,432
+1,465
+6% +$138K 1.71% 19
2025
Q3
$2.1M Buy
24,967
+1,018
+4% +$83.8K 1.39% 22
2025
Q2
$1.9M Buy
23,949
+16,202
+209% +$1.29M 1.46% 21
2025
Q1
$695K Buy
+7,747
New +$723K 0.55% 51
2024
Q4
– Hold
0
– – – 49
2024
Q3
– Hold
0
– – – 15
2024
Q2
– Hold
0
– – – 13
2023
Q4
– Hold
0
– – – 11
2023
Q3
– Hold
0
– – – 14
2023
Q2
– Hold
0
– – – 15
2023
Q1
– Hold
0
– – – 15
2022
Q4
– Hold
0
– – – 14

Other funds holding MRK

Live Oak Investment Partners's MRK Position: Q2 2026 in Review

Live Oak Investment Partners increased its Merck (MRK) stake by 0.92% in Q2 2026, buying an estimated $14.7K and bringing the position to 13,763 shares worth $1.77M. The position accounts for 0.95% of the portfolio, ranked #27.

Live Oak Investment Partners first reported a position in MRK in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.78M in Q4 2025. 3,854 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Live Oak Investment Partners held 13,763 shares of Merck worth $1.77M as of Q2 2026.
  • Live Oak Investment Partners bought 126 Merck shares in Q2 2026, an estimated $14.7K.
  • Merck made up 0.95% of Live Oak Investment Partners's portfolio in Q2 2026, its #27 holding.
  • Live Oak Investment Partners first reported a position in Merck in Q1 2025 and has held it in 6 quarters since.
  • Live Oak Investment Partners's Merck position peaked at $2.78M in Q4 2025.
  • 3,854 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Live Oak Investment Partners's 13F filing for Q2 2026, filed 10 Aug 2026.